Page 295 - Feline Cardiology
P. 295

302  Section G: Congestive Heart Failure


              Wiener-Kronish JP, Goldstein R, Matthay RA, Biondi JW, Broaddus   Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki
                 VC, Chatterjee K, et al. Lack of association of pleural effusion with   M, et al. Localization and mechanism of secretion of B-type natri-
                 chronic pulmonary arterial and right atrial hypertension. Chest   uretic  peptide  in  comparison  with  those  of  A-type  natriuretic
                 1987;92:967–970.                                  peptide  in  normal  subjects  and  patients  with  heart  failure.
              Wong  J,  Patel  RA,  Kowey  PR.  The  clinical  use  of  angiotensin-  Circulation 1994;90:195–203.
                 converting  enzyme  inhibitors.  Prog  Cardiovasc  Dis  2004;47:   Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ,
                 116–130.                                          et al. Effects of candesartan in patients with chronic heart failure
              Wright KN, Gompf RE, DeNovo RC, Jr. Peritoneal effusion in cats:   and  preserved  left-ventricular  ejection  fraction:  The  CHARM-
                 65 cases (1981–1997). J Am Vet Med Assoc 1999;214:375–381.  Preserved Trial. Lancet 2003;362:777–781.
              Wu AH, Smith A, Apple FS. Optimum blood collection intervals for   Zeitz  CJ,  Campbell  DJ,  Horowitz  JD.  Myocardial  uptake  and  bio-
                 B-type  natriuretic  peptide  testing  in  patients  with  heart  failure.   chemical and hemodynamic effects of ACE inhibitors in humans.
                 Am J Cardiol 2004;93:1562–1563.                   Hypertension 2003;41:482–487.
              Yamato M, Sasaki T, Honda K, Fukuda M, Akutagawa O, Okamoto   Zhu YC, Zhu YZ, Gohlke P, Stauss HM, Unger T. Effects of angiotensin-
                 M,  et  al.  Effects  of  torasemide  on  left  ventricular  function  and   converting  enzyme  inhibition  and  angiotensin  II  AT1  receptor
                 neurohumoral factors in patients with chronic heart failure. Circ   antagonism on cardiac parameters in left ventricular hypertrophy.
                 J 2003;67:384–390.                                Am J Cardiol 1997;80:110A–117A.
              Yang H, Woo A, Monakier D, Jamorski M, Fedwick K, Wigle ED, et   Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and
                 al. Enlarged left atrial volume in hypertrophic cardiomyopathy: A   diastolic heart failure: Part I: diagnosis, prognosis, and measure-
                 marker  for  disease  severity.  J  Am  Soc  Echocardiogr  2005;18:   ments of diastolic function. Circulation 2002;105:1387–1393.
                 1074–1082.
      Congestive Heart Failure  anemia in a kitten. J Am Vet Med Assoc. 1993;202:961–964.
              Yaphe W, Giovengo S, Moïse NS. Severe cardiomegaly secondary to
   290   291   292   293   294   295   296   297   298   299   300